# Johnson & Johnson (JNJ) — Q3-2016 Earnings Results

**Report date:** 2016-10-18 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2016

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.68 | N/A | +2.07% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's ability to navigate market challenges. They noted positive trends in consumer health and pharmaceuticals.

**Key quotes:**

> Management highlighted strong performance in key product lines.

> They emphasized ongoing commitment to innovation and market expansion.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report shows that Johnson & Johnson managed to exceed expectations on EPS, indicating some resilience in their business. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the positive EPS surprise suggests some investor optimism.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2016_